SJS Investment Consulting’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17K Buy
33
+5
+18% +$197 ﹤0.01% 2430
2026
Q2
$1.3K Buy
+28
New +$1.01K ﹤0.01% 1939
2025
Q2
– Sell
-10
Closed -$311 – 1680
2025
Q1
$311 Buy
10
+2
+25% +$67 ﹤0.01% 1373
2024
Q4
$253 Sell
8
-1
-11% -$47 ﹤0.01% 1425
2024
Q3
$522 Hold
9
– – ﹤0.01% 1312
2024
Q2
$366 Buy
9
+5
+125% +$198 ﹤0.01% 1390
2024
Q1
$168 Hold
4
– – ﹤0.01% 1514
2023
Q4
$154 Buy
4
+2
+100% +$67 ﹤0.01% 1508
2023
Q3
$62 Sell
2
-1
-33% -$35 ﹤0.01% 1580
2023
Q2
$95 Hold
3
– – ﹤0.01% 1520
2023
Q1
$110 Buy
3
+1
+50% +$35 ﹤0.01% 1452
2022
Q4
$59 Buy
2
+1
+100% +$32 ﹤0.01% 1525
2022
Q3
$0 Buy
+1
New +$46 ﹤0.01% 1618

Other funds holding ASTH

SJS Investment Consulting's ASTH Position: Q3 2026 in Review

SJS Investment Consulting increased its Astrana Health (ASTH) stake by 18% in Q3 2026, buying an estimated $197 and bringing the position to 33 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

SJS Investment Consulting first reported a position in ASTH in Q3 2022 and has held it in 13 quarters since. The position peaked at $1.3K in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • SJS Investment Consulting held 33 shares of Astrana Health worth $1.17K as of Q3 2026.
  • SJS Investment Consulting bought 5 Astrana Health shares in Q3 2026, an estimated $197.
  • Astrana Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2430 holding.
  • SJS Investment Consulting first reported a position in Astrana Health in Q3 2022 and has held it in 13 quarters since.
  • SJS Investment Consulting's Astrana Health position peaked at $1.3K in Q2 2026.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.